Almond Pharma is a Contract Research Organisation (CRO) offering Pharmaceutical and Biotechnology companies the delivery of quality, compliant and cost-effective services.

We specialise in awakening the Pharmacovigilance dormancy in Africa.

We train University graduates on Pharmacovigilance (PV), giving them the required support and skills they need for work.

Almond Pharmacovigilance services (AlmondVigilance).

This service is where companies outsource their Pharmacovigilance activities to us.

We lastly specialise in Pharmaceutical Supplies. This is where we are combating the counterfeit market by educating our clients about substandard medicines and in turn, offering them safe medicine.

[/parallax_text] [/parallax] [/full_width]

What is Pharmacovigilance?

Pharmacovigilance (drug safety) is the practice of monitoring the effects of medicinal products, i.e., drugs and vaccines.

All medicinal products within the EU, before marketing authorisation is approved is subject to a strict testing and assessment of their efficacy quality and safety.

You’re in safe hands with us

Here at Almond Pharma, our commitment is to your business as we allow you to focus on your core company, while we advance the practice of your drug safety.

Almond Pharma can offer safety and risk management services, supporting pharmaceutical, biotech, consumer health care, over-the-counter and medical devices, by providing and running your entire Pharmacovigilance operations.

We will be able to take care of all of your requirements for:

  • Case processing
  • Expedited reporting
  • Periodic safety update reports (PSURs)
  • Literature screening and safety signal detection and review.

Why are our Services so Distinct?

Not only do we offer Pharmacovigilance (PV) services globally, we specialise in awakening PV dormancy in the African countries. It is no secret that the regulatory infrastructure in the African countries border weak leaving Pharmacovigilance arguably “non-existent”. For an array of reasons, ranging from lack of Pharmacovigilance exposure (for health care professionals and patients), lack of knowledge on how to report adverse drug reactions (by health care professionals and or patients) and culture may also prohibit individuals from reporting a side effect.

Contact Us

Feel Free to Drop Us a Line

 

 

© 2020 ASAAL ltd
Registered in the UK, Company number 06830591

Back to top